@article{3087487,
    title = "High-grade B-cell lymphoma of the peritoneum as a result of transformation of a CD5-negative monoclonal B lymphocytosis population in a patient with myelodysplastic syndrome treated with 5-azacytidine",
    author = "Dimou, M. and Roumelioti, M. and Dimitrakopoulou, A. and Bitsani, C. and Kotsanti, S. and Petsa, P. and Papaioannou, P. and Kyrtsonis, M.-C. and Panayiotidis, P.",
    journal = "Clinical Lymphoma Myeloma and Leukemia",
    year = "2018",
    volume = "59",
    number = "5",
    pages = "1264-1267",
    publisher = "Taylor and Francis Ltd.",
    doi = "10.1080/10428194.2017.1375108",
    keywords = "azacitidine;  CD19 antigen;  CD20 antigen;  CD23 antigen;  CD5 antigen;  CD79b antigen;  cyclophosphamide plus doxorubicin plus prednisolone plus rituximab plus vincristine;  antineoplastic antimetabolite;  azacitidine;  CD5 antigen, aged;  anemia;  ascites fluid;  B cell lymphoma;  bone marrow biopsy;  cancer incidence;  cancer patient;  cancer staging;  case report;  chronic lymphatic leukemia;  clinical article;  comparative study;  computer assisted tomography;  cytogenetics;  DNA sequence;  erythrocyte transfusion;  flow cytometry;  human;  immunophenotyping;  Letter;  male;  medical history;  monoclonal b cell lymphocytosis;  myelodysplastic syndrome;  peritoneum tumor;  priority journal;  refractory anemia with excess blasts;  refractory cytopenia with multilineage dysplasia;  thrombocytopenia;  treatment duration;  B cell lymphoma;  chemically induced;  complication;  drug effect;  lymphocytosis;  metabolism;  myelodysplastic syndrome;  pathology;  peritoneum;  prognosis, Aged;  Antimetabolites, Antineoplastic;  Azacitidine;  CD5 Antigens;  Humans;  Lymphocytosis;  Lymphoma, B-Cell;  Male;  Myelodysplastic Syndromes;  Peritoneum;  Prognosis"
}